Scope of the Study
Calcium tablet is an important part of bones and teeth. Calcium is essential for optimal bone health. Various advantages of using calcium tablet such as prevent low blood calcium, rickets, & osteoporosis, play a role in muscle movement, assists nerves function, among others. Rising consumer awareness and an increase in purchasing power in developing countries such as China, India, among others are projected to drive the global calcium tablet market over the forecast period.
The market study is being classified by Type (Effervescent Tablets, Chewable Tablets, Sublingual Tablets and Enteric Coated Tablets) and major geographies with country level break-up.
A&Z Pharmaceutical Inc. (United States), Pfizer Inc. (United States), Amway (United Sates), Cipla Limited (India), Sun Pharmaceutical Industries Limited (India), lupin ltd (India), Sino Biopharm (China), Shijiazhuang Pharma Group (China), Zhendong Group (China) and Astellas Pharma Inc. (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Daiichi Sankyo Company (Japan).
The market is highly fragmented with the presence of various players operating in the market. Some of the key strategies followed by the players operating in the Asia Pacific calcium tablets market were innovation, product development, acquisition, and expansion. Research Analyst at AMA predicts that United, China and India Players will contribute to the maximum growth of Asia-Pacific Calcium Tablets market throughout the predicted period.
Segment Analysis
AdvanceMarketAnalytics has segmented the market of Asia-Pacific Calcium Tablets market by Type, Application and Region.
On the basis of geography, the market of Calcium Tablets has been segmented into Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Rising Consumer Awareness and an Increase in Purchasing Power
- Presence of a Large Target Patient Population in Developing Countries
Market Trend
- Rising Number of Customer from Online Channel
Restraints
- Issue related to Side Effect of Drugs such as Constipation and Nausea
- Increasing Regulatory Stringency in the Asia Pacific region
Opportunities
- High Growth Opportunities in Countries with a High Prevalence of Undernutrition
- Growing Demand from Emerging Market such as China, India, Brazil, among others
Challenges
- Safety & Quality Concerns as well as Changing Trade Policies between Countries
According to the National Center for Biotechnology Information, “The role of calcium and vitamin D in the regulation of energy balance has entered an exciting phase of research. The area receives inputs from epidemiology and clinical nutrition”. Hence, it may act hamper for market growth.
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase